Stock listing

NASDAQ:ALPN Alpine Immune Sciences Inc Stock

Follow Alpine Immune Sciences Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ALPN

$64.97 USD

Close on May 17, 2024 · No longer trades

Jul 25, 2017 to last close +580.3% · weekly closes, Jul 25, 2017 – May 17, 2024
Lowest – highest close
$2.15 – $64.97 USDSince Jul 25, 2017 · lowest Mar 17, 2020 · highest May 15, 2024

Delisted NASDAQ:ALPN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ALPN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Alpine Immune Sciences Inc on 6ix

Calls
6 calls with a replay · 6 with a transcript · latest May 6, 2024
Decks
3 decks · latest Aug 9, 2022

Events

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2022)Investor deck39 slidesAug 9, 2022
Investor Presentation (September 2018)Investor deck27 slidesSep 25, 2018
Nivalis Therapeutics — Technical Presentation (November 2016)Technical16 slidesNov 28, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
James Flynn
Other companies: Lite Strategy, Inc. (Director · Since at least Oct 31, 2023); Nuvalent, Inc. (Director · Since at least Jul 28, 2021); Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); Synlogic Inc (Director · Mar 19, 2024 – Apr 26, 2025 · Past); BiomX Inc. (Director · Mar 15, 2024 – Apr 21, 2025 · Past); Oruka Therapeutics, Inc. (Director · Jan 30, 2024 – Jan 30, 2024 · Past); RiceBran Technologies (Director · Jan 3, 2024 – Jan 3, 2024 · Past); CareMax Inc (Director · Nov 17, 2022 – Nov 17, 2023 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 28, 2023 · Past); Oncorus Inc (Director · Oct 1, 2020 – Feb 17, 2021 · Past); Acutus Medical Inc. (Director · Aug 5, 2020 – Jan 27, 2025 · Past); Deerfield Healthcare Technology Acquisitions Corp (Director · Jul 16, 2020 – Jul 21, 2020 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 6, 2019 · Past); AdaptHealth Corp. (Director · Feb 15, 2018 – Nov 8, 2019 · Past); AveXis Inc (Director · Sep 3, 2015 – Feb 10, 2016 · Past)
Director · Sep 12, 2016 – Sep 12, 2016 · Past
James N Topper
Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Frazier Lifesciences Acquisition Corp (Chief Executive Officer, Director · Dec 8, 2020 – Dec 11, 2020 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jan 18, 2019 · Past); Aptinyx Inc (Director · Jun 20, 2018 – Mar 31, 2020 · Past); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Nov 17, 2020 · Past); AnaptysBio, Inc. (Director · Jan 25, 2017 – Jan 6, 2023 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Feb 14, 2017 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jun 5, 2013 · Past); Amicus Therapeutics Inc (Director · Jun 15, 2010 – Jun 12, 2014 · Past)
Director · Jul 24, 2017 – May 18, 2024 · Past
Cynthia Smith
Other companies: Tvardi Therapeutics, Inc. (Board Member · Since at least Apr 15, 2025); Agios Pharmaceuticals, Inc. (Independent Director · Since at least Aug 11, 2022); Protara Therapeutics, Inc. (Director · Since at least Jan 29, 2021); Spero Therapeutics, Inc. (Director · Since at least Mar 19, 2019); Akebia Therapeutics, Inc. (Senior Vice President, Market Access and Commercial Development · Since at least Aug 28, 2018); Dicerna Pharmaceuticals Inc (Director · Aug 13, 2018 – Dec 28, 2021 · Past); ZS Pharma Inc (Chief Commercial Officer · Jun 17, 2014 – Dec 17, 2015 · Past)
Director · Nov 1, 2016 – Nov 1, 2016 · Past
Paul Sekhri
Other companies: Apnimed, Inc. (Director · Since at least Jul 30, 2026); vTv Therapeutics Inc. (Chairman of the Board, President and Chief Executive Officer · Since at least Aug 1, 2022); Veeva Systems Inc. (Director · Since at least Jun 22, 2016); Axcella Health Inc (Director · May 19, 2022 – May 19, 2022 · Past); Longboard Pharmaceuticals Inc (Director · Mar 11, 2021 – Dec 2, 2024 · Past); BiomX Inc. (Director · Oct 2, 2020 – Jul 28, 2021 · Past); Enumeral Biomedical Holdings Inc (Director · Dec 9, 2016 – Dec 9, 2016 · Past)
Director · Sep 12, 2016 – Jan 2, 2020 · Past
Jonathan Leff
Other companies: Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); BiomX Inc. (Director · Mar 15, 2024 – Apr 14, 2025 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Protara Therapeutics, Inc. (Director · Aug 2, 2017 – Jun 8, 2018 · Past); AveXis Inc (Director · Feb 10, 2016 – Feb 10, 2016 · Past); InterMune Inc (EVP, Research & Development · Feb 27, 2012 – Sep 29, 2014 · Past)
Director · Jun 16, 2015 – Sep 11, 2015 · Past
Xiangmin Cui
Other companies: Nuvation Bio Inc. (Director · Since at least Apr 9, 2024); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); China Biologic Products Holdings Inc (Director · Feb 4, 2010 – Jan 1, 2011 · Past)
Director · Jan 18, 2019 – May 18, 2024 · Past
Andrew Sandler M.D.
Other companies: Dermata Therapeutics, Inc. (Director · Since at least Aug 12, 2021); Dendreon Corp (EVP, Chief Medical Officer · Jan 13, 2014 – Feb 13, 2015 · Past)
Chief Medical Officer · Aug 17, 2022 – Jan 5, 2023 · Past
Christopher Peetz
Other companies: Arcutis Biotherapeutics, Inc. (Director · Since at least Jul 15, 2026); Mirum Pharmaceuticals, Inc. (CHIEF EXECUTIVE OFFICER, Director · Since at least Jul 17, 2019)
Director · Apr 20, 2018 – May 20, 2024 · Past
James Paul Rickey
Other companies: Braveheart Bio, Inc. (Chief Financial Officer · Since at least Aug 5, 2026); Immune Design Corp (VP, Finance and Administration · Jul 23, 2014 – Jan 7, 2015 · Past)
See Remarks · Jul 24, 2017 – May 20, 2024 · Past
Jay Venkatesan
Other companies: Serina Therapeutics, Inc. (Director · Since at least Feb 12, 2025); Elicio Therapeutics, Inc. (Director · Since at least May 20, 2022)
Director · Jul 15, 2022 – Jul 15, 2022 · Past
All 18 people
PersonSeat
Mark Litton
Other companies: LeonaBio, Inc. (President & CEO · Since at least Sep 17, 2020); Alder BioPharmaceuticals Inc (Chief Business Officer · May 7, 2014 – Jun 1, 2018 · Past)
See Remarks · Aug 6, 2018 – Feb 6, 2019 · Past
David Malcom Rodman
Other companies: Mineralys Therapeutics, Inc. (Chief Medical Officer · Since at least Feb 9, 2023)
Exec Vice President and CMO · Apr 18, 2016 – Jan 3, 2017 · Past
John Moore
Other companies: Edgewise Therapeutics, Inc. (General Counsel · Since at least Mar 25, 2021)
Director · Jun 16, 2015 – Sep 12, 2016 · Past
Robert E Conway
Other companies: Oruka Therapeutics, Inc. (Director · Sep 3, 2013 – Jan 30, 2024 · Past)
Director · Jun 16, 2015 – May 20, 2024 · Past
Janice TrohaExec Vice President / COO · Jun 16, 2015 – May 5, 2017 · Past
Remy DurandChief Business Officer · Apr 21, 2023 – May 20, 2024 · Past
Steven ShoemakerVP Clinical R&D · Jun 16, 2015 – Sep 11, 2015 · Past
Ulrich Martin FuhsChief Accounting Officer · Apr 3, 2024 – May 20, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Alpine Immune Sciences Inc.